Comment to FDA re: Voluntary disclosure as sesame as an allergen

Major Manufacturers Fail to Disclose Sesame, Even When Asked

More than six years have passed since CSPI and six allergy experts petitioned the FDA on November 18, 2014, for a rule to protect consumers from undeclared sesame in products.

In November 2020, FDA solicited comments on a draft guidance providing voluntary recommendations to manufacturers regarding what the agency believes are best practices for sesame labeling. This comment explains why such a guidance falls well short in addressing serious risks to sesame-allergic consumers, and why agency should replace the proposed guidance immediately with a proposed rule requiring mandatory sesame labeling.

View resource